5 Pancreatic Cancer Clinical Trials in Birmingham, AL (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting Pancreatic Cancer Studies in Birmingham

NCT02674100Recruiting

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can prov...

Birmingham, AL500 participantsUniversity of Louisville

View Study Details

NCT06807437Recruiting

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

This phase III trial compares the effect of using lanreotide before surgery to surgery alone in preventing pancreatic fistulas in patients with pancreatic cancer or a pancreatic lesion that could beco...

Birmingham, ALPHASE3274 participantsSWOG Cancer Research Network

View Study Details

NCT05764720Recruiting

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for treatment of borderline-re...

Birmingham, ALNA134 participantsVarian, a Siemens Healthineers Company

View Study Details

NCT06182072Recruiting

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

This is an open-label Phase I/Ib dose-escalation, dose-expansion clinical trial of the safety, pharmacokinetics and clinical activity of ProAgio combined with gemcitabine, nab-paclitaxel (G-nP) or gem...

Birmingham, ALPHASE146 participantsProDa BioTech, LLC

View Study Details

NCT06906562Recruiting

A Phase II Nationwide, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreas Cancer With FGFR Genetic Alterations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distan...

Birmingham, ALPHASE240 participantsSameek Roychowdhury

View Study Details

About Pancreatic Cancer Clinical Trials in Birmingham

Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.

There are currently 5 pancreatic cancer clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 994 participants. Research is being sponsored by University of Louisville, SWOG Cancer Research Network, Varian, a Siemens Healthineers Company and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pancreatic Cancer Clinical Trials in Birmingham — FAQ

Are there pancreatic cancer clinical trials in Birmingham?

Yes, there are 5 pancreatic cancer clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What pancreatic cancer treatments are being tested?

The 5 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.

Data updated July 17, 2026 from ClinicalTrials.gov